PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Evidence lacking for efficacy of memantine in treating mild Alzheimer's disease

2011-04-12
(Press-News.org) An analysis of studies involving the drug memantine finds a lack of evidence for benefit when the drug is used to treat patients with mild Alzheimer disease, according to a report posted online today that will appear in the August print issue of Archives of Neurology, one of the JAMA/Archives journals.

"Memantine, indicated for moderate to severe Alzheimer disease (AD), is frequently prescribed off-label [for uses other than those approved by the FDA] either alone or with a cholinesterase inhibitor for mild AD and mild cognitive impairment," the authors write as background information in the article. Cholinesterase inhibitors are drugs that increase levels of a brain chemical called acetylcholine. Increasing acetylcholine levels appears to slow mental decline in people with AD.

Lon S. Schneider, M.D., M.S., of the University of Southern California Keck School of Medicine, Los Angeles, and colleagues systematically searched manufacturer-sponsored meta-analyses, registries, presentations, and publications for randomized, placebo-controlled, parallel-group clinical trials of memantine in patients with mild to moderate AD. Three trials were identified that included 431 patients with mild AD and 697 patients with moderate AD. Using several different scales, the researchers assessed cognition, global change, functional activities, and behavior.

"There were no significant differences between memantine and placebo on any outcome for patients with mild AD, either within any trial or when data were combined," the authors report.

Among patients with moderate AD, there was no significant difference between memantine and placebo in any individual trial, although there was a significant effect when the three trials were statistically combined.

"Despite its frequent off-label use, evidence is lacking for a benefit of memantine in mild AD, and there is meager evidence for its efficacy in moderate AD," the authors conclude. "Prospective trials are needed to further assess the potential for efficacy of memantine either alone or added to cholinesterase inhibitors in mild and moderate AD."

###

(Arch Neurol. Published online April 11, 2011. doi:10.1001/archneurol.2011.69. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: Please see the article for additional information, including other authors, financial contributions and affiliations, financial disclosures, funding and support, etc.

To contact Lon S. Schneider, M.D., M.S., call Leslie Ridgeway at 323-442-2823 or email leslie.ridgeway@usc.edu.

END



ELSE PRESS RELEASES FROM THIS DATE:

Automatic Network Backup Features in a New Version of Handy Backup by Novosoft

2011-04-12
Novosoft, an international software development and IT consultancy company, announced the release of a new version of Handy Backup. The program presents features (automatic registration and remote installation over Active Directory among others) to help system administrators configure backup plans for windows networks. "Want me to tell you a secret of success in software development? I personally doubt there are "magic" formulas, but here is a thing that proved to be solely efficient: explore various applications of your concepts. Take Handy Backup. One of the major ...

Long-term use of antibiotic to treat acne not associated with increased bacterial resistance

2011-04-12
The prolonged use of tetracycline antibiotics commonly used to treat acne was associated with a reduced prevalence of StaphylococcuS. aureus bacteria and was not associated with increased resistance to the tetracycline antibiotics, according to a report posted online today that will appear in the August print issue of Archives of Dermatology, one of the JAMA/Archives journals. StaphylococcuS. aureus is found in both hospital and community settings. "While S. aureus colonizes the skin, it can also be responsible for localized cutaneous infections and life-threatening systemic ...

Le Meridien Amman and Starwood Hotels and Resorts Ended the Environmental and Charity Campaign with Magnificent Results

2011-04-12
Le Meridien Amman and Starwood Hotels & Resorts achieved distinguished results from its latest Charity and Environmental campaign that was launched in Middle East region as of November 1st, 2010 and lasted on 31st of January 2011. The aim of the campaign was to protect the environment and raise money to provide wheel chairs to children with disabilities. Le Meridien Amman has donated the wheelchair which was bought from this initiative to Al Hussein Society for the Habilitation and Rehabilitation of the Physically Challenged. Le Meridien Amman and more than 14 Starwood ...

Scientists flex their muscles to solve an old problem

Scientists flex their muscles to solve an old problem
2011-04-12
In a famous experiment first performed more than 220 years ago, Italian physician Luigi Galvani discovered that the muscles of a frog's leg twitch when an electric voltage is applied. An international group of scientists from Italy, the UK and France has now brought this textbook classic into the era of nanoscience. They used a powerful new synchrotron X-ray technique to observe for the first time at the molecular scale how muscle proteins change form and structure inside an intact and contracting muscle cell. The results are published in the 11 April 2011 issue of the ...

JetBoarder International Announces Worlds First Carbon Fibre JetBoarder Due for Release in July 2011

2011-04-12
The new model, to be named the 'Stealth', will be 15 Kg lighter, more rigid and able to handle more aggressive riding due to its hull construction. The idea to produce the Carbon fibre model was the brainchild of Chris Kanyaro. The initial concept being to lighten the overall weight of the current Sports Model. The new Stealth model will be much lighter, meaning more Horse Power, we expect an extra 5 - 10 K / Hr, better fuel consumption and ride. We are still in the early production phase but are due to have our prototype ready for testing in the coming month. Launch ...

Study provides new way to classify E. coli bacteria and test for fecal contamination

Study provides new way to classify E. coli bacteria and test for fecal contamination
2011-04-12
The meaning of the standard fecal coliform test used to monitor water quality has been called into question by a new study that identified sources of Escherichia coli bacteria that might not indicate an environmental hazard. Fecal pollution of surface waters is measured by the concentration of E. coli bacteria in the water because E. coli is believed to live only in the intestines and waste of humans and other warm-blooded animals, and quickly die outside its host. The presence of E. coli in water also serves as a marker for other potentially more harmful organisms that ...

Black Top Shopping.com Goes for the Gold to Bring the Power of the Coupon to Fashionistas and Emerging Designers

2011-04-12
The fashion industry has stood up and taken notice of the power behind these statistics. It's no secret that people like to save money whenever they can and fashion shoppers are no exception. While there are thousands of bargains that are highly advertised, many more are available exclusively through representatives such as Black Top Shopping. Today, the company announced the launch of registration at http://blacktopshopping.com for their members rewards program the "Gold Card Fashion Pass" which will give them access to these private sales starting April 19th. With more ...

Cancer burden shifts for people with HIV/AIDS

2011-04-12
The number of cancers and the types of cancers among people living with AIDS in the U.S. have changed dramatically during the 15-year period from 1991-2005, according to an article published online April 11th in the Journal of the National Cancer Institute. It is known that HIV-infected patients face an increased risk of Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer--the AIDS-defining cancers--and that the incidence of these cancers dropped when highly active anti-retroviral therapy (HAART) became available in the mid-1990s. People living with HIV and AIDS ...

"Judgmentless Gospel" Is No Gospel at All, Author Says, Refuting Rob Bell's Controversial New Book "Love Wins"

2011-04-12
Will only a few select people make it to heaven? Will billions of people spend eternity in hell? Many people are angry with God for allowing evil and suffering to exist in this world, and yet they are also angry with the idea of God as judge. You can't have it both ways, says Trevin Wax, associate pastor of First Baptist Church in Shelbyville, Tenn., and author of the new book Counterfeit Gospels: Rediscovering the Good News in a World of False Hope. "If you expect God to do something about the evil in this world, then you want God to judge," Wax explains. The ...

Hair styles may contribute to scarring hair loss in African-American women

2011-04-12
Hair grooming practices, such as braids and weaves, as well as inflammation in the form of bacterial infection, may be contributing to the development of scarring hair loss in African American women, according to a report posted online today that will appear in the August print issue of Archives of Dermatology, one of the JAMA/Archives journals. "Central centrifugal cicatricial alopecia (CCCA) is a term coined by the North American Hair Research Society to describe a scarring hair loss, centered on the vertex of the scalp, that spreads peripherally," the authors write ...

LAST 30 PRESS RELEASES:

Scientists trace microplastics in fertilizer from fields to the beach

The Lancet Obstetrics, Gynecology, & Women’s Health: Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities, confirms new gold-standard evidence review

Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities

Harm reduction vending machines in New York State expand access to overdose treatment and drug test strips, UB studies confirm

University of Phoenix releases white paper on Credit for Prior Learning as a catalyst for internal mobility and retention

Canada losing track of salmon health as climate and industrial threats mount

Molecular sieve-confined Pt-FeOx catalysts achieve highly efficient reversible hydrogen cycle of methylcyclohexane-toluene

Investment in farm productivity tools key to reducing greenhouse gas

New review highlights electrochemical pathways to recover uranium from wastewater and seawater

Hidden pollutants in shale gas development raise environmental concerns, new review finds

Discarded cigarette butts transformed into high performance energy storage materials

Researchers highlight role of alternative RNA splicing in schizophrenia

NTU Singapore scientists find new way to disarm antibiotic-resistant bacteria and restore healing in chronic wounds

Research suggests nationwide racial bias in media reporting on gun violence

Revealing the cell’s nanocourier at work

Health impacts of nursing home staffing

Public views about opioid overdose and people with opioid use disorder

Age-related changes in sperm DNA may play a role in autism risk

Ambitious model fails to explain near-death experiences, experts say

Multifaceted effects of inward foreign direct investment on new venture creation

Exploring mutations that spontaneously switch on a key brain cell receptor

Two-step genome editing enables the creation of full-length humanized mouse models

Pusan National University researchers develop light-activated tissue adhesive patch for rapid, watertight neurosurgical sealing

Study finds so-called super agers tend to have at least two key genetic advantages

Brain stimulation device cleared for ADHD in the US is overall safe but ineffective

Scientists discover natural ‘brake’ that could stop harmful inflammation

Tougher solid electrolyte advances long-sought lithium metal batteries

Experts provide policy roadmap to reduce dementia risk

New 3D imaging system could address limitations of MRI, CT and ultrasound

First-in-human drug trial lowers high blood fats

[Press-News.org] Evidence lacking for efficacy of memantine in treating mild Alzheimer's disease